Analyst firms · Citigroup · IVZ
Citigroup IVZ price target and rating history
Invesco Ltd (IVZ) · Finance
Citigroup rates Invesco Ltd (IVZ) Neutral with a $16 price target, as of its latest action on May 19, 2023. It has published 4 rating actions on IVZ since July 2021, including 1 upgrade and 0 downgrades. Across 4 firms with a IVZ price target in the last 12 months, the median target is $37.
- Current rating
- Neutral
- Price target
- $16
- Median target, all firms
- $37
- Actions on IVZ
- 4
Citigroup price target on IVZ
Every Citigroup rating on IVZ
- May 19, 2023
- Jan 26, 2022
- Oct 26, 2021
- Jul 12, 2021
How other firms rate IVZ
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $41 | Oct 7, 2026 |
| Keefe, Bruyette & Woods | Outperform | $39 | Sep 9, 2026 |
| Argus Research | Hold | Apr 29, 2026 | |
| RBC Capital Markets | Outperform | $35 | Jan 21, 2026 |
| Deutsche Bank | Buy | $31 | Dec 17, 2025 |
Questions about Citigroup and IVZ
- What is Citigroup's price target for IVZ?
- Citigroup's latest stated price target for Invesco Ltd (IVZ) is $16, from its action on May 19, 2023.
- What is Citigroup's rating on IVZ?
- Citigroup rates IVZ Neutral, a neutral rating, as of May 19, 2023.
- When did Citigroup last change its view on IVZ?
- On May 19, 2023, Citigroup starts coverage at Neutral, price target $16.
- How does Citigroup's IVZ target compare with other analysts?
- Across 4 firms with a IVZ price target in the last 12 months, the median target is $37.
More IVZ rating histories
- Keefe, Bruyette & Woods3
- Deutsche Bank3
- BMO Capital Markets5
- TD Cowen3
- Wells Fargo3
- Credit Suisse3
- Morgan Stanley4
All Citigroup ratingsIVZ news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.